艾伯塞拉生物 ABCL
$11.88 +$0.75 (+6.74%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $11.86 -0.16%
开盘$11.56
昨收$11.13
当日区间$11.20 – $11.98
成交量2.21M
市值$3.85B
市盈率（TTM）–
股息率–
ABCL 相关新闻
匹配 AbCellera Biologics 或代码 ABCL 的头条新闻，按最新排序。
- J.P. Morgan Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $17
- JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $25
- Goldman Sachs Initiates AbCellera Biologics(ABCL.US) With Hold Rating, Announces Target Price $13
- Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $30
- Piper Sandler Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $12
- Cantor Fitzgerald Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $12 正面
- Stifel Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $9 正面
- TD Cowen Maintains AbCellera Biologics(ABCL.US) With Buy Rating
- BMO Capital Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $15
- BMO Capital Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $15 正面
- Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $30
- JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $25 正面
- Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating
- Piper Sandler Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Cuts Target Price to $12 负面
- JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $13
暂无评论——快来第一个聊聊 ABCL。
登录后参与讨论。